chrisvoncsefalvay/vaers-outcomes huggingface dataset:
administered a 11 yr old  a 3rd dose / on 6/22, (already got 2 doses of havrix ); got a rash after the 3rd dose, patient developed a  flat red rash; This case was reported by a nurse via call center representative and described the occurrence of red rash in a 11-year-old female patient who received HAV (Havrix) (batch number YR532, expiry date 9th September 2022) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Havrix with an associated reaction of no adverse event (first dose received on 7th April 2011) and Havrix with an associated reaction of no adverse event (2nd dose received on 13th October 2011).   On 22nd June 2021, the patient received the 3rd dose of Havrix and Havrix Pre-Filled Syringe Device. In June 2021, less than a week after receiving Havrix and Havrix Pre-Filled Syringe Device, the patient experienced red rash. On 22nd June 2021, the patient experienced extra dose administered. On an unknown date, the outcome of the red rash and extra dose administered were unknown.   It was unknown if the reporter considered the red rash to be related to Havrix and Havrix Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: This case was reported by a Nurse. Nurse reported a medical assistant administered a  3rd dose of Havrix, which led to extra dose administered. The patient developed a flat red rash. No other complication. Consented to follow up.
Expiration date was yesterday and four shots were accidentally given out; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expiration date was yesterday and four shots were accidentally given out) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 29-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expiration date was yesterday and four shots were accidentally given out). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expiration date was yesterday and four shots were accidentally given out) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported.  Reportedly, the 4 doses were given to 4 patients and the vials were initially stored in the refrigerator on 26-Apr-2022. The vials did not undergo any temperature excursions.  Treatment details were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2022: Live follow up information received includes no new information.
Pt recvd 2 doses of Engerix-B on 8MAY91 & 5JUN91 & pt called reporter on 8JUL91 c/o of prolonged fatigue, dizziness, nausea, & h/a which occurred off & on for several wks p/2nd dose; no tx required; all c/o resolved;
Patient was given vaccines on the morning of 03/22/2019 and had a normal well child exam with no fever at time of vaccination. Later in the day patient started to develop a fever. On 03/23/2019 patient was brought into hospital with Dx: seizures/status epilepticus. At the time of hospitalization patient was also diagnosed with influenza A. Patient brother was diagnosed with influenza A the week prior.
Information has been received from a nurse concerning her 14 year old daughter who on 26-APR-2007 was vaccinated IM with 0.5 ml of Gardasil. On 26-MAY-2007 after she was vaccinated, the patient experienced dizziness and passed out. The patient sought unspecified medical attention. Subsequently, the patient recovered from the events. Additional information has been requested. In follow-up it was reported by the licensed practical nurse (LPN), concerning her white, 14 year old, student daughter, whose reported weight was 123 pounds and whose reported height was 65.2 inches who on 26-May-2007 was vaccinated intramuscularly (IM) with 0.5 ml of Gardasil (lot #657622/03880).  It was reported that on 25-May-2007 after the patient received the Gardasil, the patient said that she didn't feel very well and everything was black.  She was assisted to a lying position and while she was getting ready to lie down she went limp and passed out for 3 minutes.  Her name was called 2-3 times and she came "to".  I t was reported thst the patient recovered.  Additional information has been requested.
Multiple episodes of recurrent syncope on Saturday with fall. 4-6 episodes of LOC lasting minutes at a time, 2-3 minutes between episodes. Each episode of LOC followed by several seconds of confusion, then immediately back to baseline. One episode associated with urinary incontinence
The patient is 59 years old. He was scheduled to get just a flu shot. His wife was scheduled to get the flu and RSV (she is over 60). The pharmacist administered the RSV and flu to the husband by mistake. There is no adverse effect reported, just administered outside of approved age range.
I received the booster at 5pm on Monday 2/28. Tuesday afternoon 3/1 I noticed an intermittent pain in the inner side of my left breast / rib cage. Tuesday evening 3/1 I noticed my armpit was hurting me and I went to look in the mirror to see that the lymph node(s) in my armpit were extremely swollen and a bit painful. It is now Friday 3/4 at 2:30 and the pain in my armpit has went down but it is still a bit swollen and still a bit painful to touch. The pain in my chest? (not sure what to call the location) has been intermittent ever since
SORENESS UNDER ARM AND LEFT BREAST. AREA UNDER ARM FELT KIND OF WARM. COULDN'T SLEEP ON THE LEFT SIDE.
Case had Covid19 symptom onset 8/11/21 which included fever, subjective fever, runny nose, sore throat and cough. Upon Disease Investigation date of 8/16/2021 case was still symptomatic.
sore arm; shivers; fever of 101.8 F; sore neck; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st May 2019, the patient received the 1st dose of Shingrix (intramuscular). In May 2019, less than a week after receiving Shingrix, the patient experienced pain in arm, shivers, fever and neck pain. On an unknown date, the outcome of the pain in arm, shivers, fever and neck pain were unknown.   It was unknown if the reporter considered the pain in arm, shivers, fever and neck pain to be related to Shingrix.  Additional details were provided as follows:  The reporter was the concerned patient. The patient experienced sore arm, shivers and fever of 101.8 degrees F and a sore neck. The patient did not consent to follow-up.
No adverse effects other than sore arm and slight headache next day after injection. One week later, itchy near injection site. Area is red, swollen and tender.
patient stated that she had muscle Ache for 4-5 days, the area of injection felt inflamed and she felt under the weather But did not experience a fever.
patient received vaccine dose #2 and seemed fine immediately after, proceeded to leave the vaccine area and fainted, regained consciousness after just a few seconds and vomited after coming to, patient concerned resolved after incident
About 9 hours after vaccination, patient began to experience moderate arm pain and redness at the injection site (left deltoid). The patient also presented with a flat, circular pattern rash of red dots on the left forearm and hand. The rash was not itching nor painful, only red. The patient also reported sore throat without swelling nor difficulty breathing.  Pharmacist recommended Benadryl every 4 hours until rash is gone and for the patient to go to the emergency department if there is any worsening of condition (i.e. fever, wheezing, or swelling). The pharmacy will be in contact with the patient and their family throughout the week to monitor their progress.
Patient reported to be waiting for a call from HCP due to reactions she had from a flu vaccine and a TDAP shot. She reports her left arm went numb Wednesday at midnight. She states it feels like a MS flare-up.
Presented w/generalized weakness and significant orthostatics despite IV fluids. Patient was also noted to be COVID-19 positive. Initially she was saturating well on room air however later became hypoxic requiring 2L supplemental oxygen. She was therefore started on remdesivir, empiric antibiotics and steroids. She remained on 2L supplemental oxygen throughout hospitalization. Dc to Rehab
Hives, but not the day of administration. Mom's patient reported side effect 9 months later.
Rash on face/chest, upper arm, scale, with 2" inf. around nostril Rash started around 12/28 seen in office on 1/6/05.
within about 5 minutes after the injection I got warm and flushed feeling all over my body, my body started feeling tingly all over even my tongue, but it never swole.  My HR went up to the 160s, my BP was elevated to like 166/80.  I was given 25mg benedryl, which calmed the flushed feeling and I was monitored for about 30 minutes and finally my BP and went back down to around 130/70 and my body normalized out besides the tingling which lasted the remainder of the day.  I had a little nausea.  I went back to work and finished out the day.  I took more benedryl when I got home to help with the tingling feeling which finally deminished after about 24 hrs.
I had some hives on my face and now from last couple of days I had some hives around my eyes.; my eyes are really red, like hives all over them and they hurt and they itch; my eyes are really red, like hives all over them and they hurt and they itch; my eyes are really red, like hives all over them and they hurt and they itch; This is a spontaneous report from a contactable consumer or other non health professional (patient). A 48-year-old female patient received  bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number:ENG203) via an unspecified route of administration, administered in arm left on 27Feb2021 (age at vaccination 48 years) as dose 1, single for COVID-19 immunization. Medical history included asthma, thyroid disorder, high blood pressure and post-traumatic stress disorder. Concomitant medications included tiotropium bromide (SPIRIVA), levothyroxine sodium (SYNTHROID), venlafaxine hydrochloride (EFFEXOR), carvedilol (COREG), prazosin, dexlansoprazole (DEXILANT). It was unknown whether patient received any other vaccine in four weeks. Covid prior vaccination and Covid tested post vaccination was reported as unknown. It was reported as unknown whether the patient was pregnant. It was reported that patient had the vaccine on 27Feb2021 and shortly after that she had some hives on her face and now from last couple of days she had some hives around her eyes on Mar2021 and her eyes were really red, like hives all over them and they hurt and they itch on an unspecified date in 2021. Treatment received was reported as unknown. The outcome of the event she had some hives on her face and now from last couple of days she had some hives around her eyes was not recovered while the outcome of the event her eyes were really red, like hives all over them and they hurt and they itch was unknown.  No follow-up attempts are possible. No further information is expected.
Almost blacking out twice; Pinkish coloring in urine, darker and darker until red tint; vaccine administered Midway in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PRESYNCOPE (Almost blacking out twice), CHROMATURIA (Pinkish coloring in urine, darker and darker until red tint) and PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (vaccine administered Midway in the arm) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     No relevant medical history provided.  Concomitant products included ALBUTEROL SULFATE for an unknown indication.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (vaccine administered Midway in the arm). On 21-Apr-2021, the patient experienced CHROMATURIA (Pinkish coloring in urine, darker and darker until red tint). On 22-Apr-2021, the patient experienced PRESYNCOPE (Almost blacking out twice). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. On 14-Apr-2021, PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (vaccine administered Midway in the arm) had resolved. On 22-Apr-2021, CHROMATURIA (Pinkish coloring in urine, darker and darker until red tint) had resolved. On 24-Apr-2021, PRESYNCOPE (Almost blacking out twice) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient taking oral aspirin 81mg daily "to prevent blood clot." No treatment information reported for dizzy spells.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
It started with sniffles which progressed to a very stuffy nose, a scratchy throat, and a hacking cough. On the 3rd day, I saw a doctor. I tested positive for COVID-19. He prescribed cough medicine. He told me to go to the hospital if I had trouble breathing, but that never happened. I quarantined for 5 days. By the 10th day, I felt fine and traveled back home.
BLISTER LIKE RAS ON RIGHT THIGH. PAPULE RASH ON CHEST & TORSO
The evening of after receiving vax, the pt experienced swollen lips and generalized hives. She went to the ER eleven days later with shortness of breath and swollen throat. She is currently being seen by an allergist and dermatologist. She is being treated with prednisone and several antihistamines. The physician reported that the pt experienced "severe" generalized urticaria/angioedema beginning in July 2000. The severe urticaria occurred daily. Reportedly, she did well with prednisone burst therapy, bu tthe hives recurred whenever te prednisone was discontinued. The hives were eventually suppreased 6 months after onset. In approx Oct 2000, hives started to disappear. Reportedly, the physician stated that "the hives are probably leaving my system by now." The physician reported that the urticaria resolved in October 2000. The vaccinee reported on 02/07/2000 that she was still experiencing the same events "on and off." She is currently being seen by an allergist and dermatologist. Engerix-B was discontinued. The physician stated that the urticaria was possibly related to Engerix-B. A different physician stated that the event was idiopathic. As 04/24/2001, the outcome of the event was resolved.
semi paralized; This spontaneous case was reported by a consumer and describes the occurrence of PARALYSIS (semi paralized) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PARALYSIS (semi paralized) (seriousness criteria hospitalization and medically significant). At the time of the report, PARALYSIS (semi paralized) outcome was unknown.            Concomitant medication of the patient was not reported.  At the time of reporting, the patient was at 20th day of hospitalization.  No treatment information was provided by the reporter.  Very limited information regarding this event has been provided at this time.; Sender's Comments: Very limited information regarding this event has been provided at this time.
Left deltoid aching next day. Aching progressed to entire arm.  Had nasal dryness with postnasal drip and subsequent stomach ache; these symptoms resolved within the first week.  Sustained baseline change as of 12/13/2021 includes trouble with onset, duration, quality of sleep as well as reduced exertional tolerance.  New onset of increased labored breathing.  Intermittent transient episodes of dyspnea and chest pain post-exercise.
This spontaneous report as received from a nurse refers to unspecified number of patients of unknown age and gender. Pertinent medical history was unknown. On an unknown date an unspecified number of patients were vaccinated with PNEUMOVAX 23 (route of administration, dose and anatomical location was unknown) that underwent another temperature excursion. Concomitant medications were unspecified by reporter. No adverse effects reported. The outcome of the events was unknown. No further information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
High Fever 102 - 104 ( Jan 23-26, 2017 ) Rashes (01-25-17) Fuzziness Lack of appetite, refusing to drink milk/fluids Swollen lymph nodes.
Initially received pfizer covid vaccine. Had Moderna booster 11/2 and within 24 hours developed urticaria in axilla and groin. Pruritic rash spreading across chest, abdomen, back and down arms. No evidence of respiratory involvement at this time.
I took my first dose and I tested positive for COVID; I took my first dose and I tested positive for COVID; This is a spontaneous report from a contactable consumer (patient). A male patient of unspecified age received BNT162B2 (Solution for injection), via unspecified route of administration on an unspecified date (Batch/Lot number was unknown) at singe dose for covid-19 immunisation. The patient's medical history was not reported. Concomitant medication included phenytoin (DILANTIN [PHENYTOIN]). The patient did not receive any treatment. Patient did not receive any other vaccine in four weeks. It was reported that the patient tested positive for COVID after the first dose of the vaccine. Patient also reported that his parents too tested positive for COVID after vaccination. The patient read vaccination don't give you, you can't get COVID from being vaccinated. The patient's dads doctor told him he don't need to be vaccinated no more cause his dad has cancer and he read that Pfizer did not test the drug on cancer patient. The patient underwent lab tests and procedures which included sars-cov-2 test: positive. Outcome of the events was unknown.     Follow-up attempts are completed. No further information is expected.
While clerk was going thru billing it was found that this patient had received 2 High Dose Flu Vaccines. One dose of the high dose flu vaccine was given at off site location during flu out reach on 09/20/2022 and the other dose was given in the clinic on 11/07/2022.
On 02/19/2023, at 11:00AM, I wasn't feeling well.  I left church and was going to go home, but instead went to the Emergency Room because my heart was beating so fast. They gave me some medication to slow my heart down. They took an MRI to make sure I didn't have any blockage. I am better now.
Mom called on 3/5/01 and reported that on 3/2/01, the pt's right leg became very red and extremely swollen and bruised with a rash from knee to top of thigh. It was very tender to touch and unable to walk on leg. Also, had fever of 102.5F until 3/4/01. Treated with Benadryl po and Tylenol.
Pain at injection site, fever.  19x9cm erythema, heat, tenderness at left lateral arm.
Hemoglobin dropped to 6.2; A spontaneous report was received from a consumer concerning a 86-year-old, elderly male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and his hemoglobin dropped  to 6.2/hemoglobin decreased.   The patient's medical history, as provided by the reporter, included cancer. Concomitant medications were not provided.  On 16 Feb 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 015M20A) intramuscularly for prophylaxis of COVID-19 infection.   On an unspecified date, the patient's hemoglobin dropped to 6.2 due to which he was hospitalized. Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not provided.   The outcome of event hemoglobin dropped to 6.2 was unknown at the time of this report.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
THE PATIENT INCORRECTLY RECEIVED THE MONOVALENT COVID VACCINE AS A THIRD DOSE INSTEAD OF THE BIVALENT COVID VACCINE.
Pt. called PA-C to c/o headache, tingling across forehead/scalp, tenderness above right eyebrow which was a bit swollen and red. Pt. advised to monitor and follow up with pcp if not better or if sx. worsening.
Teacher noted rash started at approx 12:30 on face, spread to both cheeks, chin, chest and back and became hivelike. Called to room at 13:01. 13:02 child lethargic and stable VS, 911. 13:04 called dad with report, rc'd hospital and Dr name. 13:06 911 here. Becoming more red and swollen. 13:13 removed by squad.  11/02/09 Medical records received for DOS 10/23/09. Ped ED record. Child developed itchy rash, mild urticaria and flushed blotchy face, chest and upper back 1hr s/p vaccine. Also expsoed to air freshener (playing with) the night before. TX Benadryl. Redenss decreased. D/C to home. Follow-up revealed slept well, no issues.
Incorrect vaccination for age--had been given first dose Moderna in error in March; given second dose Moderna per CDC guidance.
My appt was at 7:40 PM but they were running late so I think the reaction started about 20-30 minutes after the injection. My lips, mouth and nose tingled for about 10 minutes.  I felt my heart race a few times. The 2nd day, my skin felt like it was on fire and my hands and feet hurt.  I also had a low fever and exhaustion.  The 3rd day I just felt exhausted. The 4th day I am  feeling tired and a bit faint. I also noticed a couple of red blotches  with crust on my face and chest, and below my left inner eye  was red, puffy and swollen.
Missed the 2nd dose of Moderna COVID-19 Vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed the 2nd dose of Moderna COVID-19 Vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed the 2nd dose of Moderna COVID-19 Vaccine). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed the 2nd dose of Moderna COVID-19 Vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported.
Patient stated he never received a covid 19  vaccination or any other vaccination per heath questionnaire, no other form of verification is used to determine if patient is telling the truth. This writer found out due to immunization supervisor that this patient had received the Moderna vaccination prior. This writer was asked to fill out Vaers form.